Order Article Reprints

Wang W, Tsuchiya K, Kurosaki M, Yasui Y, Inada K, Kirino S, Yamashita K, Sekiguchi S, Hayakawa Y, Osawa L, et al. Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice. Cancers. 2019; 11(10):1517. https://doi.org/10.3390/cancers11101517

Wang, Wan, Kaoru Tsuchiya, Masayuki Kurosaki, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, and et al. 2019. "Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice" Cancers 11, no. 10: 1517. https://doi.org/10.3390/cancers11101517

Wang, W., Tsuchiya, K., Kurosaki, M., Yasui, Y., Inada, K., Kirino, S., Yamashita, K., Sekiguchi, S., Hayakawa, Y., Osawa, L., Okada, M., Higuchi, M., Takaura, K., Maeyashiki, C., Kaneko, S., Tamaki, N., Nakanishi, H., Itakura, J., Takahashi, Y., ... Izumi, N. (2019). Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice. Cancers, 11(10), 1517. https://doi.org/10.3390/cancers11101517